These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 16305598

  • 1. Distribution of intranasal C-zolmitriptan assessed by positron emission tomography.
    Yates R, Sörensen J, Bergström M, Antoni G, Nairn K, Kemp J, Långström B, Dane A.
    Cephalalgia; 2005 Dec; 25(12):1103-9. PubMed ID: 16305598
    [Abstract] [Full Text] [Related]

  • 2. Blood-brain barrier penetration of zolmitriptan--modelling of positron emission tomography data.
    Bergström M, Yates R, Wall A, Kågedal M, Syvänen S, Långström B.
    J Pharmacokinet Pharmacodyn; 2006 Feb; 33(1):75-91. PubMed ID: 16402287
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers.
    Yates R, Nairn K, Dixon R, Kemp JV, Dane AL.
    J Clin Pharmacol; 2002 Nov; 42(11):1244-50. PubMed ID: 12412823
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study.
    Gawel M, Aschoff J, May A, Charlesworth BR, REALIZE Study Group.
    J Headache Pain; 2005 Oct; 6(5):405-11. PubMed ID: 16362714
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bioequivalence study of 2 orodispersible formulations of zolmitriptan 5 mg in healthy volunteers.
    Cánovas M, Canals M, Polonio F, Cabré F.
    Arzneimittelforschung; 2012 Oct; 62(10):482-6. PubMed ID: 22918855
    [Abstract] [Full Text] [Related]

  • 14. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
    Abd-Elal RM, Shamma RN, Rashed HM, Bendas ER.
    Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.